Peter Kolchinsky, Director, 10% Owner at DICE Therapeutics, Inc. (DICE), bought 1,640,000 shares at $36.50 ($59.9M) on 2022-10-17, disclosed to the SEC on 2022-10-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| VOR | SELL | 2025-10-30 | $20.7M | — | Filing → |
| CDTX | BUY | 2025-06-30 | $100.0M | — | Filing → |
| TYRA | BUY | 2025-06-06 | $23.5M | — | Filing → |